Article
Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.
Genetics and molecular research : GMR - 9 Jan 2012
Scibona P, Redal M A, Garfi L G, Arbelbide J, Argibay P F, Belloso W H
Abstract excerpt
Dicumarinic oral anticoagulants have a narrow therapeutic range and a great individual variability in response, which makes calculation of the correct dose difficult and critical. Genetic factors involved in this variability include polymorphisms of genes that encode the metabolic enzyme CYP2C9 and the target enzyme vitamin K epoxide reductase complex 1 (VKORC1); these polymorphisms can be associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
